16 July 2023>: Clinical Research
A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy
Hanzhao Yang CDE , Yadong Sun BCD , Peili Wang BD , Jianghua Qiao BC , Lianfang Li B , Zhenduo Lu B , Xianfu Sun B , Chongjian Zhang B , Xiuchun Chen B , Min Yan B , Shude Cui B , Chengzheng Wang ADF , Zhenzhen Liu AE*DOI: 10.12659/MSM.940124
Med Sci Monit 2023; 29:e940124
Figure 1 The nomogram to predict patients with ≥4 positive total ALNs in HR+/HER2− population with 1–2 positive SLNs. The scores for the 4 factors were summed to calculate the probability of ≥4 positive total ALNs and the total scores and bottom risk scale were referenced. R software 4.1.1 (The R Foundation for Statistical Computing, Austria, Vienna).